Your browser doesn't support javascript.
loading
Dual targeting of mTORC1/C2 complexes enhances histone deacetylase inhibitor-mediated anti-tumor efficacy in primary HCC cancer in vitro and in vivo.
Shao, Huanjie; Gao, Chun; Tang, Haikuo; Zhang, Hao; Roberts, Lewis R; Hylander, Bonnie L; Repasky, Elizabeth A; Ma, Wen W; Qiu, Jingxin; Adjei, Alex A; Dy, Grace K; Yu, Chunrong.
Affiliation
  • Shao H; Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY 14263, USA.
J Hepatol ; 56(1): 176-83, 2012 Jan.
Article in En | MEDLINE | ID: mdl-21835141

Full text: 1 Database: MEDLINE Main subject: Transcription Factors / Proteins / Carcinoma, Hepatocellular / Histone Deacetylase Inhibitors / Liver Neoplasms Type of study: Prognostic_studies Language: En Journal: J Hepatol Journal subject: GASTROENTEROLOGIA Year: 2012 Type: Article Affiliation country: United States

Full text: 1 Database: MEDLINE Main subject: Transcription Factors / Proteins / Carcinoma, Hepatocellular / Histone Deacetylase Inhibitors / Liver Neoplasms Type of study: Prognostic_studies Language: En Journal: J Hepatol Journal subject: GASTROENTEROLOGIA Year: 2012 Type: Article Affiliation country: United States